“…Other antibodies used in this study were blot-purified rabbit polyclonal antibodies R5932 (vs. LC1; Benashski et al, 1999), R5391 (vs. LC2;Patel-King et al, 1997), R4930 (vs. LC3;Patel-King et al, 1996), CT61 (vs. LC4; M. Sakato and King, unpublished data), R4929 (vs. LC5;Patel-King et al, 1996), R4928 (vs. LC6; King and Patel-King, 1995), R7178 (vs. LC7a;Bowman et al, 1999), CT116 (vs. LC7b;DiBella et al, 2004a), R4058 (vs. LC8; King and Patel-King, 1995), and anti-DC 2 (Wakabayashi et al, 2001), and mouse monoclonal antibodies 12␥B (vs. ␥ HC; King et al, 1985), 1878A (vs. IC1; King et al, 1986), and 1869A (vs. IC2; King et al, 1985). Antibody reactivity was detected using peroxidase-conjugated secondary antibodies and an enhanced chemiluminescent substrate (GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom).…”